ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE

Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: D. B. Erdyneeva, N. N. Babyshkina, T. A. Dronova, S. V. Vtorushin, E. M. Slonimskaya, V. N. Stegniy, N. V. Cherdyntseva
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: Tomsk National Research Medical Center of the Russian Academy of Sciences 2020-09-01
Sarja:Sibirskij Onkologičeskij Žurnal
Aiheet:
hormone-receptor positive breast cancer
cyclin d1
tamoxifen
resistance mechanisms
Linkit:https://www.siboncoj.ru/jour/article/view/1540
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia